The APP will provide comprehensive inpatient management of patients with advanced cardiovascular disease, including acute and chronic heart failure, ventricular assist devices (VADs), heart transplant candidates and recipients, and patients requiring temporary mechanical circulatory support such as Impella, intra-aortic balloon pump (IABP), and extracorporeal membrane oxygenation (ECMO). In collaboration with physicians, nurses, pharmacists, and ancillary team members, the APP will play an integral role in delivering exceptional, evidence-based care to a complex and critically ill patient population.